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a b s t r a c t
Objective: The adjustable pulmonary artery band (APAB) has been demonstrated by us earlier
to be superior to the conventional pulmonary artery banding (CPAB), in terms of reduced
early morbidity and mortality. In this study, we assessed the adequacy of the band and its
complications over the mid-term.
Methods: Between 2002 and 2012, 73 patients underwent adjustable PAB, and their operative
and follow-up data were collected and analyzed.
Results: There was one early death following the APAB. Follow-up data were available for 57
patients of which 44 patients (61.7%) underwent deﬁnitive repair, 10 were awaiting deﬁnitive
repair, and 3 patients were kept on medical follow-up because of inadequate fall in
pulmonary artery (PA) pressures. 14 patients (19%) were lost to follow-up. Major PA distor-
tion or stenosis was absent in the majority. 1 patient had pseudoaneurysm of the main
pulmonary artery (MPA) with sternal sinus infection and required surgical reconstruction. 1
patient had infective endocarditis of the pulmonary valve managed medically. Band migra-
tion was not encountered. There were two deaths after deﬁnitive repair and one after APAB.
Conclusions: Patients undergoing APAB fulﬁlled the desired objectives of the pulmonary
artery banding (PAB) with minimum PA complications in the mid-term. This added to the
early postoperative beneﬁts, makes the APAB an attractive alternative to the CPAB.
# 2015 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.
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Since pulmonary artery banding (PAB) was ﬁrst described in
1952, by Muller and Dammann,1 its indications have
progressively diminished as a temporary palliation for only* Corresponding author.
E-mail address: sachintalwar@hotmail.com (S. Talwar).
http://dx.doi.org/10.1016/j.ihj.2015.06.036
0019-4832/# 2015 Cardiological Society of India. Published by Elseviea few subsets of patients who are not better surgical
candidates for deﬁnitive repair, those requiring re-training
of the regressed left ventricle in transposition of great
arteries or those who require control of pulmonary artery
(PA) blood ﬂow and pressure as a part of staged univen-
tricular palliation.2r B.V. All rights reserved.
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been associated with high morbidity and mortality and a high
reoperation rate, which has not diminished appreciably.3–7
This has prompted development of the concept of adjustable
pulmonary artery banding (APAB), where the pulmonary blood
ﬂow can be controlled to tide over a period of hemodynamic
instability in these patients, who often do not tolerate a
sudden increase in the afterload to the ventricle. The APAB has
been demonstrated to be superior to CPAB in terms of
reduction in early morbidity and mortality. However, whether
the advantage holds true in the mid-term needs to be studied.
This study therefore aims to analyze the outcomes of APAB
in the mid-term in terms of the reduction of PA pressures and
suitability for deﬁnitive palliation and to study the band-
related complications encountered at deﬁnitive surgery.
2. Methods
The hospital records of all patients undergoing APAB between
January 2002 and December 2012, at the All India Institute of
Medical Sciences, New Delhi, India, were retrospectively
reviewed. Only patients undergoing isolated PAB were
included in the study. All patients who underwent additional
procedures, such as repair of coarctation of aorta and atrial
septectomy, were excluded. The study protocol was duly
approved by the ethics committee of the institute and
informed consent was obtained from all patients. After APAB,
patients were followed up at one week, one month, and 3
months and then at 6 monthly intervals on outpatient basis
and underwent clinical examination, echocardiography, and
cardiac catheterization or CT angiography for progression to
the next stage according to the univentricular or biventricular
pathway. All the data were collected from the cardiac clinic
ﬁles of these patients and were analyzed in detail. After
excluding one death that occurred at the initial APAB, the
study population comprised of 72 patients (45 male) with a
wide range of diagnoses (Table 1). The mean age at APAB was 3
 2.4 (0.5–132) months and the mean weight at APAB was 3.8
 0.4 (1.8–21) kg. Desirable reduction in PA pressures was
deﬁned as mean PA pressure of 15 mmHg and/or 1/3rd of theTable 1 – Cardiac diagnosis and the distribution of univentricu
adjustable pulmonary artery banding.
Univentricular 
1 Tricuspid atresia with non-restrictive ventricular septal defect,
pulmonary arterial hypertension = 12
2 Atrioventricular septal defect with pulmonary arterial hypertensi
(unbalanced) = 4
3 Single ventricle with pulmonary arterial hypertension = 4 
4 Double outlet right ventricle with ventricular septal defect (non-
routable) with pulmonary arterial hypertension = 3
5 Congenitally corrected transposition of great arteries with ventric
septal defect = 3
6 Double inlet left ventricle, ventricular septal defect, pulmonary a
hypertension = 4
Total = 30 mean systemic arterial pressure with systemic saturation of at
least above 75% for univentricular repair, and in patients with
biventricular repair, mean PA pressure of 1/3rd to 1/2 of mean
systemic arterial pressure and saturation of at least above
85%.8,9 The technique of APAB has been described by us in
detail in our prior publications.10,11 Brieﬂy, in this technique
(Fig. 1), the MPA was looped with a No. 2 Ethibond (Johnson &
Johnson Inc, Somerville, NJ) suture after passing a right-angle
forceps between the aorta and the MPA. This right-angle
forceps was again passed and the suture end was grasped
again, so that the MPA was doubly looped. The two ends of this
suture were passed through a 0.5  0.5-cm polytetraﬂuor-
oethylene (PTFE) pledget, which was anchored to the adventi-
tia of the MPA using interrupted 5-0 polypropylene suture.
Both arms of the suture were clipped together with a Ligaclip
(LT 200; Ethicon Endosurgery Inc, Cincinnati, OH) just on the
pledget. These sutures were brought out through the pericar-
dium and the lateral edge of the sternum and then through
subcutaneous tissue and skin. After sternal closure, the two
ends of the suture were passed through another 1–2 cm PTFE
pledget, and these were clipped together with a big Ligaclip (LT
400, Ethicon Endosurgery). The ends of the suture were then
tied to form a loop. Subsequent band tightening was achieved
by placing additional big Ligaclips between the external PTFE
pledget and the previously placed Ligaclip. Echocardiography
was used to monitor the early postoperative gradients across
the band. Once satisfactory gradients were achieved; the band
was internalized by simply opening one of the skin sutures,
clipping the two ends of the Ethibond suture against the
sternum using a small Ligaclip, and cutting the Ethibond
suture above it.
3. Results
There was 1 early death in the initial APAB procedure due to
sudden cardiorespiratory arrest. The parents of this patient did
not consent for an autopsy. Of the 72 survivors, follow-up data
were available for 57 (79%) patients. Mean follow-up was 33
 28 months (median 30 months, range, 3–156 months). 54
of the 57 (94.7%) patients had desirable reduction in their PAlar vs. biventricular physiology in patients undergoing
Biventricular
1 Large ventricular septal defect = 10
on 2 Multiple ventricular septal defects = 20
3 Atrioventricular septal defects = 5
4 Double outlet right ventricle, ventricular septal
defect, pulmonary arterial hypertension = 5
ular 5 Congenitally corrected transposition of great
arteries, ventricular septal defect, pulmonary
arterial hypertension = 2
rterial
Total = 42
Fig. 1 – The technique of adjustable pulmonary artery
banding. The Ethibond suture is doubly looped around the
pulmonary artery (PA), passed through a
polytetrafluoroethylene (PTFE) pledget (T) and a clip (C) is
applied to both the threads flush with the pledget. They are
then passed through the pericardium, sternum,
subcutaneous tissue, and skin and through another PTFE
pledget (TT) and another clip (CC) is applied above the TT
before being tied together to form a loop. Subsequent
tightening is by placing additional clips between the
outside clip (CC) and the TT.
Reproduced with permission from: Choudhary et al.10
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underwent deﬁnitive repair depending on their univentricular
or biventricular pathway. Intracardiac repair was performed in
25 patients with PA reconstruction. In the univentricularpathway, 15 patients underwent the bidirectional superior
cavopulmonary anastomosis and the remaining 4 patients
underwent the total cavopulmonary connection. The remain-
ing 10 patients were waiting for their deﬁnitive repair. 14 (19%)
patients were lost to follow-up. 3 (4%) patients were advised
medical follow-up. One patient who was 3 years old, with a
diagnosis of double outlet right ventricle with multiple
ventricular septal defects (VSDs), had a band gradient of only
36–44 mmHg and was advised medical follow-up because a
bidirectional superior cavopulmonary anastomosis was not
considered feasible at this hemodynamics and because of
increased age there were concerns about pulmonary vascular
disease not amenable to band tightening. Second patient was
2.5 years old, with a large muscular VSD with hypoplasia of the
right ventricle. On cardiac catheterization, his PA pressures
were 36/12 with a mean of 23 mmHg. He has been on medical
follow-up and it is expected that the PA pressures will fall
further when the child ‘‘grows into the band’’. The third
patient was 7 years old with a diagnosis of Swiss cheese
septum. His PA pressures continue to be high and the smaller
VSDs have not closed yet, so he is presently on medical follow-
up as he is asymptomatic. He is planned to be kept in
observation and if needed, repeat cardiac catheterization and
surgery will be performed as deemed necessary.
The most common associated surgical procedure required at
the time of deﬁnitive repair was PA de-banding and placement
of a patch on the PA to correct the band-induced main PA
stenosis. However, there was no branch PA stenosis (Fig. 2).
Band migration was not observed. However, one patient had a
pseudoaneurysm of the MPA with sternal sinus infection, which
was repaired successfully at the time of deﬁnitive repair with an
autologous pericardial patch. One patient was found to have
endocarditis affecting the pulmonary valve at 2 years of follow-
up after the APAB, which resolved with medical management.
This patient has been lost to follow-up since then and awaits
deﬁnitive repair. There were two deaths after deﬁnite repair due
to low cardiac output syndrome. Six patients developed
postoperative low output syndrome, two in patients following
repair of multiple VSDs closure and a large single VSD in the
biventricular group and four following Glenn (n = 1) and Fontan
(n = 3). Two of these died (one following multiple VSD closure
and one following Fontan); the rest recovered. PA reconstruction
was performed in patients in the biventricular group at the time
of deﬁnitive repair by either a direct PA plasty (n = 4), or by
augmentation with a pericardial patch (n = 15) or a PTFE patch
(n = 4). We did not prefer to resect the segment of the PA with the
band with end-to-end anastomosis of the PA. In patients
undergoing the bidirectional Glenn anastomosis, the main PA
was always transected if the antegrade ﬂow was not left open. In
patients undergoing the Fontan operation, it was always
transected. All these PA procedures were accomplished without
difﬁculty and the technique of prior APAB did not pose any
technical problems. One patient developed complete heart
block and needed a permanent pacemaker.
4. Discussion
The principle of APAB was introduced in 1972 by Fishman and
Roe to tide over the period of hemodynamic instability induced
Fig. 2 – Pulmonary artery injection in (a) anteroposterior and (b) lateral views showing the band (*) in position without any
migration or branch pulmonary artery stenosis.
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load to the pulmonary ventricle due to band placement. The
introduction of a telemetrically controlled adjustable PAB
(FloWatch®-PAB—EndoArt S.A., Lausanne, Switzerland), by
Corno,12 allows control of the narrowing of the PA weeks, or
even months, after the operation. Even though six decades
have passed since the PAB was ﬁrst described, the CPAB
remains an enigma. Determination of the optimal band
tightness is difﬁcult and often unreliable, as described by
Poiseuille's law, minimal changes to the pulmonary diameter
have a high impact on the resistance and ﬂow.12,13 In addition,
various physiological factors such as systemic and pulmonary
vascular resistances, type of congenital heart defect, heart
rate, cardiac contractility, presence or absence of chest
infection, and mechanical ventilation have an impact on the
PA pressures and gradients across the PAB. Patients with
univentricular physiology exhibit an age-related variability of
the ventricular adaptive response and they require progressive
band tightening over a period of time.7 As a result of all these
problems requiring repeated surgical procedures to achieve
desired band diameter, the concept and need for adjustable PA
banding arose and was used increasingly thereafter. We
developed our own method of adjustable PA banding,10 which
was reported earlier, and its superiority over conventional PA
banding11 was also subsequently reported. However, we felt
the need to study the results of the procedure in the mid-term
to assess whether our objectives were met or not and whether
there were any signiﬁcant complications resulting from this
particular method of APAB, as there was some criticism at the
time of reporting of this technique that this method may lead
to the tenting of the MPA toward the sternum with signiﬁcant
PA distortion and difﬁculties at re-operation. Also there were
concerns that the band would cut through the PA over a period
of time or would loosen and lead to inadequate band gradients.
However, as our results have demonstrated, these concerns
appear to be misplaced. The need to perform a plasty of the
main PA is expected after any type of PAB. Removal of the PABsuture at re-operation did not pose any technical difﬁculties
and major PA reconstructions were not needed, as there were
no instances of band migration following this type of band.
Corno12 has demonstrated no need for PA plasty following the
use of FloWatch device for APAB; however, we believe that PA
plasty is a low-risk procedure and the cost effectiveness of our
modiﬁcation (only Rs 1000 expenditure toward disposable
items compared to US dollars 5000 of FloWatch device) is an
advantage in developing countries.
5. Study limitations
One of the limitations of this study is the lack of follow-up of
100% patients. Nearly 20% patients were not contactable
and this could have led to an overestimation of the efﬁcacy
of the procedure. However, in the remaining patients,
comprehensive echocardiographic, cardiac catheterization
data, and operative information were available, enabling us
to draw the present conclusions. The patient population
comprises a wide range of ages and diagnoses and the end-
points as to when a ‘‘success’’ is said to have been achieved
is not clearly deﬁned, especially in the group with
biventricular physiology, where even a loose band may be
enough to tide over the initial critical phase, and a tight
band is not mandatory.
6. Conclusions
Patients undergoing APAB achieved adequate palliation over
the mid-term and either proceeded to or were awaiting
deﬁnitive repair. Signiﬁcant band-related complications were
not encountered. The technique of APAB described by us is
thus advantageous not only in the short-term as demonstrat-
ed by us previously, but is also associated with acceptable mid-
term results.
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